The Silicon Therapeutics computational physics platform provides us with an exceptional ability to advance therapeutics toward curative outcomes for patients. This proprietary discovery engine, based on conformational genetics and leading-edge molecular simulations, enables us to model interactions at the atomic level and gain singular insights into critical protein targets.
Mutant-Selective Antagonist Oncology
Allosteric Phosphatase Modulator Oncology
Antagonist Autoinflammatory Disease